In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Statistics Quarterly, Q2 2003

Executive Summary

In Vivo presents another installment of our quarterly reivew of dealmaking--in this case April-June 2003. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
Advertisement

Related Content

Millennium's P&L-Based Strategy and the Ortho/J&J Deal
Millennium's P&L-Based Strategy and the Ortho/J&J Deal
Chiron/PowderJect: US Snaps Up Europe's Best
Abbott Moves One Way in Cardiovascular Devices, Another in Orthopedics, To Get To the Same Place
Tularik & Amgen: A Model of Business Development (and Good News for Biotech, Too)
Abbott Moves One Way in Cardiovascular Devices, Another in Orthopedics, To Get To the Same Place
Tularik & Amgen: A Model of Business Development (and Good News for Biotech, Too)
J&J Strikes Again in Spine
J&J Strikes Again in Spine

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002156

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel